DARC Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # AF6695H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse, Rat
Applications
Immunohistochemistry, Western Blot, Flow Cytometry, CyTOF-ready
Label
HRP
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant mouse DARC
Met1-Pro61, Ala115-Cys127, Ser186-Lys205, Tyr264-Asn285
Accession # NP_034175
Met1-Pro61, Ala115-Cys127, Ser186-Lys205, Tyr264-Asn285
Accession # NP_034175
Specificity
Detects mouse and rat DARC in Western blots.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for DARC Antibody [HRP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: DARC
Long Name
Duffy Antigen, Receptor For Chemokines
Alternate Names
ACKR1, CD234, Duffy Antigen, Fy Antigen, GPD, GpFy
Gene Symbol
ACKR1
Additional DARC Products
Product Documents for DARC Antibody [HRP]
Product Specific Notices for DARC Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...